225 related articles for article (PubMed ID: 34399806)
1. Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images.
Persson E; Emin S; Scherman J; Jamtheim Gustafsson C; Brynolfsson P; Ceberg S; Gunnlaugsson A; Olsson LE
Radiat Oncol; 2021 Aug; 16(1):150. PubMed ID: 34399806
[TBL] [Abstract][Full Text] [Related]
2. Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
Gustafsson C; Persson E; Gunnlaugsson A; Olsson LE
J Appl Clin Med Phys; 2018 Nov; 19(6):185-192. PubMed ID: 30354010
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z
Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008
[TBL] [Abstract][Full Text] [Related]
4. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
Gustafsson C; Korhonen J; Persson E; Gunnlaugsson A; Nyholm T; Olsson LE
Med Phys; 2017 Nov; 44(11):5563-5574. PubMed ID: 28803447
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
[TBL] [Abstract][Full Text] [Related]
6. MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria.
Persson E; Jamtheim Gustafsson C; Ambolt P; Engelholm S; Ceberg S; Bäck S; Olsson LE; Gunnlaugsson A
Radiat Oncol; 2020 Apr; 15(1):77. PubMed ID: 32272943
[TBL] [Abstract][Full Text] [Related]
7. Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer.
Korsager AS; Carl J; Riis Østergaard L
J Appl Clin Med Phys; 2016 May; 17(3):294-303. PubMed ID: 27167285
[TBL] [Abstract][Full Text] [Related]
8. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
[TBL] [Abstract][Full Text] [Related]
10. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
[TBL] [Abstract][Full Text] [Related]
11. Validation of a deformable MRI to CT registration algorithm employing same day planning MRI for surrogate analysis.
Padgett KR; Stoyanova R; Pirozzi S; Johnson P; Piper J; Dogan N; Pollack A
J Appl Clin Med Phys; 2018 Mar; 19(2):258-264. PubMed ID: 29476603
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of automatic deformable structure propagation for high-field MRI guided prostate radiotherapy.
Christiansen RL; Dysager L; Bertelsen AS; Hansen O; Brink C; Bernchou U
Radiat Oncol; 2020 Feb; 15(1):32. PubMed ID: 32033574
[TBL] [Abstract][Full Text] [Related]
13. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancer.
Christiansen RL; Jensen HR; Brink C
Acta Oncol; 2017 Jun; 56(6):787-791. PubMed ID: 28464739
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
[TBL] [Abstract][Full Text] [Related]
16. Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement.
Knybel L; Cvek J; Blazek T; Binarova A; Parackova T; Resova K
Radiat Oncol; 2021 Dec; 16(1):235. PubMed ID: 34876173
[TBL] [Abstract][Full Text] [Related]
17. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments.
Langen KM; Zhang Y; Andrews RD; Hurley ME; Meeks SL; Poole DO; Willoughby TR; Kupelian PA
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1517-24. PubMed ID: 16029814
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.
Barkati M; Simard D; Taussky D; Delouya G
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):255-9. PubMed ID: 26568515
[TBL] [Abstract][Full Text] [Related]
19. Observer uncertainties of soft tissue-based patient positioning in IGRT.
Hirose TA; Arimura H; Fukunaga JI; Ohga S; Yoshitake T; Shioyama Y
J Appl Clin Med Phys; 2020 Feb; 21(2):73-81. PubMed ID: 31957964
[TBL] [Abstract][Full Text] [Related]
20. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]